Tianxing Medical (01609.HK) Hong Kong public offering is subscribed 7,823.13 times, raising approximately HK$7.584 billion in net proceeds from global offering.

The Chinese financial news app Zhitong Finance reported that Tianxing Medical (01609.HK) announced the results of its distribution. The company globally sold 8,421,900 H shares, with 10% available for public sale in Hong Kong and 90% for international sale. The sale price per share was 98.5 Hong Kong dollars, raising approximately 758.4 million Hong Kong dollars in net proceeds. Trading of H shares is expected to begin on the Hong Kong Stock Exchange on Tuesday, May 5, 2026, at 9:00 am, with every 50 shares per lot.